Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward
12. März 2025 08:30 ET
|
Dogwood Therapeutics, Inc.
ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical company focused on advancing first-in-class,...
Next-Gen Cancer Treatment: Rakovina’s AI-Driven ATR Inhibitors Enter Preclinical Testing
12. März 2025 08:30 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, March 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through...
CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
12. März 2025 08:00 ET
|
CG Oncology Inc.
CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
10. März 2025 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
Music of Your Life Launches Street Talk
07. März 2025 10:59 ET
|
The Marquie Group, Inc.
TMGI subsidiary Music of Your Life launches syndicated radio program as company continues focuse on cancer awareness.
Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda in Glioblastoma
07. März 2025 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda
Plus Therapeutics Announces New Employment Inducement Grants
05. März 2025 16:01 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Announces New Employment Inducement Grants
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
05. März 2025 12:15 ET
|
Siren Biotechnology, Inc.
Siren Biotechnology expands Clinical and Scientific Advisory Board with key industry leaders
Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds
04. März 2025 14:06 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds
Irazú Oncology Secures Bridge Funding, Expands Leadership Team and Facilities
04. März 2025 08:30 ET
|
Irazu Oncology
Dr. Mayukh Das, joined Irazú as CMO, bringing extensive oncology drug development experience from leadership roles at global pharmaceutical companies.